Drug Treatment of Hyperuricemia to Prevent Cardiovascular Outcomes: Are We There Yet?

By Gaffo Angelo L.   Saag Kenneth G.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Practical metabolomics in drug discovery

By Wilcoxen Keith M   Uehara Taisuke   Myint Khin Than   Sato Yoshiaki   Oda Yoshiya  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 3, 2010-03 ,pp. : 249-263

Informa Healthcare

Access to resources Recommend Favorite

The future of plant drug discovery

By Littleton John  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 673-683

Informa Healthcare

Access to resources Recommend Favorite

Lipophilicity in drug discovery

By Waring Michael J  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 3, 2010-03 ,pp. : 235-248

Informa Healthcare

Access to resources Recommend Favorite

The importance of chronobiology to drug discovery

By Farrow Stuart N   Solari Roberto   Willson Timothy M  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 535-541

Informa Healthcare

Access to resources Recommend Favorite